CXCL12 and central nervous system cancer: Furthermore, chemokine (CXCL-12) was found to increase vascular endothelial growth factor (VEGF) production by CD133+ glioma stem-like cells via the activation of the PI3K/Akt signaling pathway, resulting in enhanced angiogenesis and metastasis [38].